ApprovalTrail

Approval · Notice of Compliance 2892 · 1998

PROSCAR: Notice of Compliance 2892

Issued November 12, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2892
Date
November 12, 1998
Company
Merck Frosst Canada Inc.Kirkland, QC, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Revised indication
Therapeutic class
Type 11 5 alpha-reductase inhibitor

Products in this notice

BrandDINStatus today
PROSCARNot yet assigned—

Medicinal ingredients